Mairs & Power Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.8M Sell
401,968
-10,782
-3% -$1.03M 0.36% 54
2025
Q4
$39.6M Sell
412,750
-17,822
-4% -$1.73M 0.38% 48
2025
Q3
$41M Sell
430,572
-24,718
-5% -$2.27M 0.39% 46
2025
Q2
$39.7M Sell
455,290
-82,893
-15% -$7.03M 0.39% 47
2025
Q1
$48.4M Sell
538,183
-237,176
-31% -$21.2M 0.5% 46
2024
Q4
$61.9M Sell
775,359
-1,194,109
-61% -$103M 0.6% 44
2024
Q3
$177M Sell
1,969,468
-970,474
-33% -$81.6M 1.67% 24
2024
Q2
$231M Sell
2,939,942
-46,637
-2% -$3.82M 2.24% 13
2024
Q1
$260M Buy
2,986,579
+48,622
+2% +$4.15M 2.52% 12
2023
Q4
$242M Sell
2,937,957
-19,516
-0.7% -$1.49M 2.55% 12
2023
Q3
$232M Buy
2,957,473
+135,806
+5% +$11.4M 2.72% 10
2023
Q2
$249M Sell
2,821,667
-729
-0% -$62.8K 2.7% 11
2023
Q1
$228M Buy
2,822,396
+21,027
+0.8% +$1.71M 2.63% 12
2022
Q4
$218M Buy
2,801,369
+15,999
+0.6% +$1.3M 2.62% 10
2022
Q3
$225M Buy
2,785,370
+217,977
+8% +$19.6M 2.84% 10
2022
Q2
$230M Sell
2,567,393
-66,231
-3% -$6.71M 2.76% 10
2022
Q1
$292M Sell
2,633,624
-95,746
-4% -$10.1M 2.94% 7
2021
Q4
$282M Sell
2,729,370
-6,711
-0.2% -$777K 2.62% 10
2021
Q3
$343M Sell
2,736,081
-24,367
-0.9% -$3.15M 3.43% 7
2021
Q2
$343M Sell
2,760,448
-80,313
-3% -$10.1M 3.39% 6
2021
Q1
$336M Sell
2,840,761
-57,253
-2% -$6.71M 3.52% 6
2020
Q4
$339M Buy
2,898,014
+6,642
+0.2% +$731K 3.77% 5
2020
Q3
$300M Buy
2,891,372
+40,153
+1% +$4.03M 3.75% 4
2020
Q2
$261M Buy
2,851,219
+27,731
+1% +$2.66M 3.42% 5
2020
Q1
$255M Sell
2,823,488
-116,954
-4% -$12.4M 3.72% 4
2019
Q4
$334M Sell
2,940,442
-32,343
-1% -$3.55M 3.79% 5
2019
Q3
$323M Sell
2,972,785
-114,277
-4% -$11.9M 3.9% 4
2019
Q2
$301M Buy
3,087,062
+25,758
+0.8% +$2.35M 3.61% 5
2019
Q1
$279M Sell
3,061,304
-26,154
-0.8% -$2.34M 3.39% 6
2018
Q4
$281M Sell
3,087,458
-149,735
-5% -$14M 3.79% 4
2018
Q3
$318M Sell
3,237,193
-227,206
-7% -$21M 3.71% 4
2018
Q2
$297M Sell
3,464,399
-204,096
-6% -$17M 3.68% 4
2018
Q1
$294M Buy
3,668,495
+27,872
+0.8% +$2.3M 3.63% 5
2017
Q4
$294M Buy
3,640,623
+86,568
+2% +$6.93M 3.41% 7
2017
Q3
$276M Buy
3,554,055
+68,629
+2% +$5.7M 3.32% 7
2017
Q2
$309M Buy
3,485,426
+11,520
+0.3% +$971K 3.74% 5
2017
Q1
$280M Buy
3,473,906
+331,827
+11% +$25.9M 3.43% 6
2016
Q4
$224M Buy
3,142,079
+181,493
+6% +$14.3M 2.87% 10
2016
Q3
$256M Sell
2,960,586
-34,232
-1% -$2.98M 3.37% 5
2016
Q2
$260M Sell
2,994,818
-22,882
-0.8% -$1.85M 3.51% 5
2016
Q1
$226M Sell
3,017,700
-125,455
-4% -$9.45M 3.22% 9
2015
Q4
$242M Sell
3,143,155
-28,767
-0.9% -$2.17M 3.62% 4
2015
Q3
$212M Sell
3,171,922
-41,522
-1% -$3.06M 3.32% 5
2015
Q2
$238M Sell
3,213,444
-41,004
-1% -$3.13M 3.37% 5
2015
Q1
$254M Sell
3,254,448
-142,048
-4% -$10.8M 3.49% 4
2014
Q4
$245M Sell
3,396,496
-371,542
-10% -$25.8M 3.4% 6
2014
Q3
$233M Sell
3,768,038
-378,114
-9% -$24M 3.41% 5
2014
Q2
$264M Buy
4,146,152
+21,855
+0.5% +$1.33M 3.75% 2
2014
Q1
$254M Buy
4,124,297
+33,495
+0.8% +$1.95M 3.76% 3
2013
Q4
$235M Buy
4,090,802
+2,563
+0.1% +$145K 3.61% 4
2013
Q3
$218M Sell
4,088,239
-95,068
-2% -$5.12M 3.76% 3
2013
Q2
$215M Buy
+4,183,307
New +$207M 4.12% 2

Other funds holding MDT

Mairs & Power Inc's MDT Position: Q1 2026 in Review

Mairs & Power Inc reduced its Medtronic (MDT) stake by 2.6% in Q1 2026, selling an estimated $1.03M and leaving 401,968 shares worth $34.8M. The position accounts for 0.36% of the portfolio, ranked #54.

Mairs & Power Inc first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $343M in Q3 2021. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Mairs & Power Inc held 401,968 shares of Medtronic worth $34.8M as of Q1 2026.
  • Mairs & Power Inc sold 10,782 Medtronic shares in Q1 2026, an estimated $1.03M.
  • Medtronic made up 0.36% of Mairs & Power Inc's portfolio in Q1 2026, its #54 holding.
  • Mairs & Power Inc first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Mairs & Power Inc's Medtronic position peaked at $343M in Q3 2021.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Mairs & Power Inc's 13F filing for Q1 2026, filed 14 May 2026.